Skip to Main Content

Paper Details

Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.
J Clin Invest
22
2019
GVHD, H2O2, IFN, NFB, RTrx1, T cell, T-bet, Thioredoxin-1, Thioredoxin1, Trx1, Trx1-, Trx1-Tg, Trx1-Tg donor T cells, alloreactive donor T cells, donor T cells, graft-versus-host disease, graft-versus-leukemia, human, human Trx1, human Trx1-transgenic, human recombinant Trx1, mouse, mouse and human T cells, oxygen
Author NameAffiliation
Nilanjana MaulikUniversity of Connecticut Health Center
Shikhar Mehrotra
  • 1 - 2

Datasets

Release 1.2